ACTB Methylation in Blood as a Potential Marker for the Pre-clinical Detection of Stroke: A Prospective Nested Case-Control Study

BACKGROUND: Stroke is the second leading cause of death worldwide. If risk of stroke could be evaluated early or even at a preclinical stage, the mortality rate could be reduced dramatically. However, the identified genetic factors only account for 5–10% of the risk of stroke. Studies on the risk fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chunlan, Yin, Qiming, Li, Mengxia, Fan, Yao, Shen, Chong, Yang, Rongxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160447/
https://www.ncbi.nlm.nih.gov/pubmed/34054407
http://dx.doi.org/10.3389/fnins.2021.644943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160447/
https://www.ncbi.nlm.nih.gov/pubmed/34054407
http://dx.doi.org/10.3389/fnins.2021.644943

Ejemplares similares